2021
DOI: 10.3389/fendo.2021.793718
|View full text |Cite
|
Sign up to set email alerts
|

Case Report and Systematic Review: Sarcomatoid Parathyroid Carcinoma—A Rare, Highly Malignant Subtype

Abstract: BackgroundParathyroid carcinoma (PC) is a rare malignancy, the incidence of which is less than 1/1 million per year. Sarcomatoid parathyroid carcinoma (SaPC) is an extremely peculiar subtype; only three cases have been reported internationally. It consists of both malignant epithelial components and sarcomatoid components (mesenchymal origin) simultaneously. This “confusing” cancer exhibits higher invasiveness, and traditional surgery does not appear to achieve the expectation, which differs significantly from… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 67 publications
0
2
0
Order By: Relevance
“…In patients with parathyroid carcinoma associated with secondary hyperparathyroidism undergoing dialysis, the characteristic clinical ndings observed only in parathyroid carcinoma do not necessarily apply due to the additional modi cations caused by dialysis. [43,44,45]. No obvious differences were noted in age, sex ratio, PTH level, or presence of bone lesions between groups.…”
Section: Discussionmentioning
confidence: 98%
“…In patients with parathyroid carcinoma associated with secondary hyperparathyroidism undergoing dialysis, the characteristic clinical ndings observed only in parathyroid carcinoma do not necessarily apply due to the additional modi cations caused by dialysis. [43,44,45]. No obvious differences were noted in age, sex ratio, PTH level, or presence of bone lesions between groups.…”
Section: Discussionmentioning
confidence: 98%
“…Table 4 presents a comparison of the age, sex ratio, serum calcium level, PTH level, and presence of bone lesions in patients with and without secondary hyperparathyroidism [ 47 – 49 ]. No obvious differences were noted in age, sex ratio, PTH level, or presence of bone lesions between groups.…”
Section: Discussionmentioning
confidence: 99%